Everpure FY2026 revenue climbs 16% to $3.7 billion; subscription annual recurring revenue rises 16% to $1.9 billion

Reuters
Yesterday
<a href="https://laohu8.com/S/PSTG">Everpure</a> FY2026 revenue climbs 16% to $3.7 billion; subscription annual recurring revenue rises 16% to $1.9 billion
  • FY2026 other income (expense), net jumped 75% to $109 million on higher net foreign exchange gains and a gain from the sale of an equity security.
  • FY2026 net cash provided by operating activities climbed to $880 million from $754 million.
  • FY2026 total revenue grew 16% to $3.7 billion on higher product revenue and subscription services revenue.
  • FY2026 research and development expense increased 20% to $725 million on higher employee compensation and related costs.
  • FY2026 sales and marketing expense rose 17% to $1.1 billion on higher employee compensation, including sales commission expense, and higher events and travel costs.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Everpure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001474432-26-000027), on March 25, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10